← Back to Insights
July 1, 2015
Download PDF 
David W. Johnson
Consumerism Innovation Outcomes

No One is an Island: Meaningful Second Opinions

Market Corner Commentary: July 1, 2015-No One is an Island: Meaningful Second Opinions

A good friend (let’s call him John Donne) in his mid-fifties recently wrote describing his treatment for early-stage prostate cancer.  He titled his message “Cure vs. Treatment”

John’s journey starts terribly, but ends well. Lessons abound.

Before sharing John’s story, it’s helpful to revisit the Hippocratic Oath (modern version[1]). Among its other covenants, the Oath stresses the following:

  • Holistic care: physicians treat “sick human beings” not “fever charts” nor “cancerous growths”
  • Appropriate care: avoid “overtreatment” and “therapeutic nihilism”
  • Knowledge sharing and consultation
  • Self-awareness, empathy and humility: understand personal limitations
  • Prevention “is preferable to cure”

Consider the Hippocratic Oath while reading John’s letter.


Love your commentaries!

I was recently and awkwardly ‎introduced to the dark side of healthcare, as I just finished external beam radiation and Brachytherapy for early prostate cancer. 

What I came across was so evil and scary (across the board) – the level of greed and ethical corruption in conventional cancer care is unfathomable. 

My local doc checked my PSA and referred me with a “just over the threshold score” to a urologist within his system. When I asked for another opinion, there was an eight-week wait for an appointment.

The local yokel urologist did a biopsy, found two of eighteen samples malignant and observed the following:

  • Surgery ‎was really my only option. He dismissed radiation with a roll of the eyes. Seriously, no words, just an eyeroll.  He said that his new Da Vinci (branded robot) was the coolest thing. He’d done almost a hundred procedures in his career “which might as well be a million.”


  • Questioned how much I valued ‎my sexual function because “there are a lot of nerves that might accidently get severed”; and


  • I stood a really good chance of living ten years ‎longer.

I just smiled and vowed never to see his face again. I know an “aw shucks” huckster when I see one.I called my scientist brother. He referred me to a prostate cancer specialist, who stopped counting at five thousand procedures. My good friend, a retired banker, had just done a nationwide search for a similar condition and recommended the same specialist. 

The specialist concluded I had two options: surgery (not robotic, which is considered experimental); or Brachytherapy, the seed implants.  I was not a good candidate for surgery, since the three tumors were in difficult places and would require retreatment within five years. 

The specialist further noted that Brachytherapy has a ninety-seven percent cure rate with a two percent chance of incontinence and near-zero chance of impotence. He recommended five weeks external beam radiation combined with Brachytherapy.  I just finished the treatments with no side effects.

 I asked him why other docs prescribe high-risk treatments when less risky, more curative therapies exist. He said that each case is very different depending on the patient’s age, health and tumor characteristics.

He would not throw another physician under the bus. What I see, however, is a guy in a hospital system paying for his Da Vinci machine and his Mercedes.  With his prescribed treatment, his health system could bill up to twenty procedures ‎instead of just one or two. If side affects emerged from my bad decision (getting just one treatment opinion from the local yokel), so much the better for the health system. 

I have never seen such ‎a corruption of “sacrosanct trust.” You can throw out the “Hypocritical Oath”!

The AMA won’t adjudicate protocols because their statistical methodology allows for broad interpretations that keep the big health systems’ “treatment machines” rolling. 

That “doctors” are free to market their treatments as “best practice” is a sham.  It’s sad my local doctor could not warn me about the medical circus I was entering, since he is an integral part of the circus too.

My father-in-law got caught in this mess a few years ago and died of liver cancer that started in his prostate. He trusted his local-yokel urologist to remove all the cancerous tumors. The last two years of his life were unbearable due to chemo treatments.  Still, his hospital billed his insurance early and often.

It is really sad that that a local yokel feels free to weigh my life and well-being‎ against his need to pay off expensive equipment and “feed” his parent health system through misdiagnosis and overtreatment of well-insured individuals.

I know I am preaching ‎to the choir, but this is a real conspiracy that touches average people and they suffer from it.


Where to begin? The Hippocratic Oath is a good place.  Grounded in ancient Greek philosophy, it mandates patient-centered care, humility and consultation.  John experienced none of these behaviors until he connected with the national specialist.

John is a highly educated and very capable professional with an expansive network.  These attributes enabled him to resist and overcome health system pressure for expensive, inappropriate and likely harmful treatment. Good for him.

It’s his last sentence, however, that haunts me.  Don’t all individuals, regardless of their circumstances, deserve meaningful second opinions when confronting scary medical diagnoses?

The revenue-first mindset that governs U.S. medicine resists external interventions. It drives high volumes of profitable procedures through aligned facilities. As John’s story demonstrates, patient needs are too often secondary considerations.

Emerging Market Solutions

Competitive markets respond to customer needs by developing solution-oriented products and services. There is a huge unmet need for meaningful second opinions.

Not surprisingly, the marketplace is responding to this need.  Multiple “second-opinion” companies are emerging.  Their specialists review diagnoses and recommend treatment regimens. They suggest adjustments as warranted.

Grand Rounds and Pinnacle Care are industry leaders in providing independent second opinions. Two-thirds of Grand Rounds’ case reviews recommend different treatment regimens. Two-thirds! In forty percent of Grand Rounds’ reviews of prescribed surgeries, there experts recommend non-surgical therapies.  The result is better, less harmful, more compassionate and more cost-effective care.

The current customers for second-opinion companies are wealthy individuals and self-insured employers.  Companies pay small per-member-per-month fees to cover their employees.

In consumer-driven reform, the market for independent second opinions will expand to counteract healthcare’s information asymmetry (John’s “local-yokel” problem).  Enlightened payors and providers will offer independent second opinions to engaged customers and win their loyalty.

No One is an Island

I chose my friend’s pseudonym purposefully.

John Donne is the best-known of England’s seventeenth-century metaphysical poets. The following paragraph in Donne’s eloquentMeditation #17 (written in 1623) inspired the title for Ernest Hemmingway’s best-selling novel For Whom the Bell Tolls and Simon and Garfunkel’s 1965 hit song, “I am a Rock”.No man is an island, entire of itself; every man is a piece of the continent, a part of the main. If a clod be washed away by the sea, Europe is the less, as well as if a promontory were, as well as if a manor of thy friend’s or of thine own were: any man’s death diminishes me, because I am involved in mankind, and therefore never send to know for whom the bell tolls; it tolls for thee.

When American medicine misdiagnoses and overtreats, it diminishes consumers’ confidence in the entire healthcare system. The American people deserve better.  Independent, expert second opinions conducted in full consultation with patient customers should be our standard of care. Consumer-driven reform demands better healthcare services and the market is responding.

We all are in this together.

Correction: The June 24th commentary misidentified John Travolta’s character in “Welcome Back, Kotter” as Arnold Horshack.  His actual character’s name is Vinnie Barbarino.  Dumb mistake – hard to imagine any Travolta character named Arnold.

[1] Written in 1964 by Louis Lasagna, Academic Dean of the School of Medicine at Tufts University, and used in many medical schools today.

About the Author

David W. Johnson

David Johnson is the CEO of 4sight Health, an advisory company working at the intersection of healthcare strategy, economics, innovation. Johnson is a healthcare thought leader, keynote speaker, and strategic advisor to organizations busting the status-quo to reform our healthcare system. He is the author of Market vs. Medicine: America’s Epic Fight for Better, Affordable Healthcare, and his second book, The Customer Revolution in Healthcare: Delivering Kinder, Smarter, Affordable Care for All (McGraw-Hill 2019). As a speaker, Dave plays the role of rebel, challenger, industry historian, investor and company evaluator to push audiences forward. (Watch bio video.) Johnson applies his 25+ years of investment banking in healthcare to identify ways the healthcare industry must change to deliver better care. He received a Masters in Public Policy from Harvard Kennedy School, an English degree from Colgate University, and served in the African Peace Corp service. Join over 10k+ healthcare executives who read our weekly insights and commentary on www.4sighthealth.com. His third book, Less Healthcare, More Health: The Prescription for a Happier, More Equitable and Productive America, will publish in 2024.

Recent Posts

Podcast: How Healthcare Revolutionaries Think With Melina Davis
Podcast: Melina Davis on Doctors Opening Up About Burnout One of the big problems in healthcare is physician… Read More
By June 20, 2024
Prior Authorization Is a Big Waste of Time 
Prior authorization (PA) has been and continues to be a huge thorn in the side of healthcare providers… Read More
By June 19, 2024
Podcast Playlist: GLP-1 Drugs
Credit where it’s due: 4sight Health’s Julie Murchinson predicted the popularity of GLP-1 drugs long before the mainstream… Read More
By June 18, 2024